Global Prefilled Syringe Market Growth Forecast
Analysis based on 6 articles · First reported May 25, 2026 · Last updated Jun 08, 2026
The pre-filled syringe market is projected for significant growth, driven by increasing demand for biologics, vaccines, and self-administration therapies. This growth will positively impact key players like BD>>> and Gerresheimer>>>, as well as the broader pharmaceutical and medical device industries.
The global pre-filled syringe market is experiencing substantial growth, with projections indicating a rise from approximately US$ 4,698 million in 2025 to US$ 5,700 million by 2032, and from USD 8.65 billion in 2026 to USD 14.53 billion by 2031, according to reports by QYResearch and MarketsandMarkets>>>. This expansion is fueled by the increasing adoption of biopharmaceuticals, vaccines, and self-administered therapies for chronic conditions, which benefit from the convenience, accuracy, and patient compliance offered by pre-filled syringes. Key industry trends include a shift towards advanced polymer syringes, low silicone oil formulations, dual-chamber designs, and integration with automated devices. Regulatory compliance is also driving innovation, with competition moving towards integrated solutions. North American Cobalt Inc.>>> and Europe>>> currently hold dominant market shares, while MSCI Asia Pacific Index>>>, particularly China>>> and Japan>>>, shows rapid growth. Leading companies such as BD>>>, Gerresheimer>>>, SCHOTT AG>>>, KC Pharmaceuticals>>>, AptarGroup>>>, Nipro>>>, and Baxter International>>> are investing in manufacturing capacity and new technologies, such as BD>>>'s USD 35 million investment in United States — Nebraska>>> and Gerresheimer>>>'s partnership with Injecto>>> for silicone-oil- and PFAS-free systems.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard